Literature DB >> 10348464

Bradykinesia and impairment of EEG desynchronization in Parkinson's disease.

P Brown1, C D Marsden.   

Abstract

It has been suggested that the basal ganglia control the release of cortical elements from low-frequency rhythmic idling activity during voluntary movement. This hypothesis was tested by recording the local idling rhythms of the motor cortex, the alpha and beta rhythms, in 12 untreated and treated patients with Parkinson's disease as they moved a wrist. Recordings were made after overnight withdrawal of medication and again 1 hr after levodopa. The treatment-related attenuation of the alpha and beta rhythms picked up over the cortical motor areas contralateral to the active arm correlated with the improvement in size and speed of movement effected by levodopa. The distribution and degree of attenuation depended on the complexity of the task. These results demonstrate for the first time a specific effect of levodopa on the organization of motor cortical activity in the frequency domain, an effect that correlates with improvements in bradykinesia.

Entities:  

Mesh:

Year:  1999        PMID: 10348464     DOI: 10.1002/1531-8257(199905)14:3<423::aid-mds1006>3.0.co;2-v

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

1.  High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor.

Authors:  R Levy; W D Hutchison; A M Lozano; J O Dostrovsky
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Hand preshaping in Parkinson's disease: effects of visual feedback and medication state.

Authors:  Luis F Schettino; Sergei V Adamovich; Wayne Hening; Eugene Tunik; Jacob Sage; Howard Poizner
Journal:  Exp Brain Res       Date:  2005-07-22       Impact factor: 1.972

3.  Differentiation between the contributions of shortening reaction and stretch-induced inhibition to rigidity in Parkinson's disease.

Authors:  Ruiping Xia; Douglas Powell; W Zev Rymer; Nicholas Hanson; Xiang Fang; A Joseph Threlkeld
Journal:  Exp Brain Res       Date:  2011-02-24       Impact factor: 1.972

4.  Synchrony Drives Motor Cortex Beta Bursting, Waveform Dynamics, and Phase-Amplitude Coupling in Parkinson's Disease.

Authors:  Andrew B O'Keeffe; Mahsa Malekmohammadi; Hiro Sparks; Nader Pouratian
Journal:  J Neurosci       Date:  2020-06-23       Impact factor: 6.167

5.  Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease.

Authors:  Daniel Weiss; Rosa Klotz; Rathinaswamy B Govindan; Marlieke Scholten; Georgios Naros; Ander Ramos-Murguialday; Friedemann Bunjes; Christoph Meisner; Christian Plewnia; Rejko Krüger; Alireza Gharabaghi
Journal:  Brain       Date:  2015-01-02       Impact factor: 13.501

6.  200-300Hz movement modulated oscillations in the internal globus pallidus of patients with Parkinson's Disease.

Authors:  Christos Tsiokos; Xiao Hu; Nader Pouratian
Journal:  Neurobiol Dis       Date:  2013-02-04       Impact factor: 5.996

7.  Time-frequency analysis of movement-related spectral power in EEG during repetitive movements: a comparison of methods.

Authors:  David P Allen; Colum D MacKinnon
Journal:  J Neurosci Methods       Date:  2009-11-10       Impact factor: 2.390

8.  High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model.

Authors:  Jonathan E Rubin; David Terman
Journal:  J Comput Neurosci       Date:  2004 May-Jun       Impact factor: 1.621

9.  Apomorphine-induced differences in cortical and striatal EEG and their glutamatergic mediation in 6-hydroxydopamine-treated rats.

Authors:  Vasily Vorobyov; Frank Sengpiel
Journal:  Exp Brain Res       Date:  2008-08-06       Impact factor: 1.972

10.  Interactions between cortical rhythms and spiking activity of single basal ganglia neurons in the normal and parkinsonian state.

Authors:  Plamen Gatev; Thomas Wichmann
Journal:  Cereb Cortex       Date:  2008-10-08       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.